At present, with the continuous promotion of policies such as centralized procurement, consistency evaluation, and medical insurance negotiation, generic drugs with low added value and low clinical value are gradually being eliminated, and innovation has begun to become the general trend of the development of the pharmaceutical industry
.
It is worth noting that in this context, while the demand for pharmaceutical equipment in the pharmaceutical industry is expanding, the requirements are also increasing
.
Domestic pharmaceutical equipment companies are accelerating the road to differentiated innovation! (Image source: Pharmaceutical Network)
In this regard, the industry said that China's pharmaceutical equipment industry will move forward in the direction of high-quality development, which is both an opportunity and a challenge for pharmaceutical equipment companies
.
Because to promote high-quality development, the way out is innovation, and the difficulty is also innovation
.
So, for the pharmaceutical equipment industry, how can we get out of the road of "innovation"?
Analysts pointed out that the pharmaceutical equipment industry belongs to the direct upstream industry of the pharmaceutical industry and is an important guarantee for the industrial upgrading and technological progress of the pharmaceutical industry
.
Therefore, its innovation should mainly start from promoting the research and development investment of new products and new technologies, as well as introducing innovative talents, so as to enhance the company's core competitiveness
.
It is reported that at present, there are many domestic pharmaceutical equipment with R&D strength and capital that have been increasing the investment in innovative R&D and carrying out diversified and differentiated innovations in equipment and technology to help pharmaceutical companies develop higher quality
.
For example, the domestic pharmaceutical equipment solid preparation Xinma Pharmaceutical is building a pharmaceutical equipment industrialization project, which is expected to be officially put into operation by the end of this year
.
It is estimated that the sales revenue will be 1.
2 billion yuan, the annual profit will be 180 million yuan, the annual tax payment will be 52 million yuan, and the number of new jobs will be 500
.
It is reported that after the completion of the project, a whole industrial chain of solid preparation-laboratory, customized, production-type and closed-type production lines will be formed
.
The R&D and design capability is the key point of the differentiated and specialized competition of pharmaceutical equipment enterprises
.
At present, the needs of pharmaceutical enterprises are diversified.
In the case of rising costs year by year, overall solution providers can better meet the needs of enterprises than the research and development of a single pharmaceutical equipment.
This is also the upgrade of many domestic pharmaceutical equipment enterprises.
one big direction
.
For example, Canaan Technology has been able to provide pharmaceutical companies with professional, customized, integrated and intelligent solid preparation intelligent factory complete line equipment and supporting process design solutions through continuous investment, with process design capabilities and core equipment.
R&D and manufacturing capabilities
.
In the future, the company will continue to deepen its strategic layout, strive to become a solution provider for the whole line of pharmaceutical equipment smart factories, and continue to advance in depth in the big health industry
.
It is worth mentioning that, with the advancement of favorable policies related to "smart manufacturing" and the development of new technologies such as industrial big data, informatization, and intelligence, the automation and intelligence of pharmaceutical equipment have also become the direction of industry upgrading.
A number of new models of pharmaceutical equipment smart factories have emerged
.
Among them, Chutian Technology is very active in this regard
.
It is reported that Chutian Technology has been deploying since 2010, researching and developing automated and intelligent overall solutions, and the annual research and development investment accounts for 8% to 10% of sales revenue
.
As far as the author understands, the new smart manufacturing model project launched in February 2016 has passed the acceptance around July this year
.
Among them, the intelligent manufacturing factory is an important manifestation of the new model project of Chutian Technology's intelligent manufacturing, which is a flexible and agile intelligent factory to meet the needs of the production of various types of pharmaceutical equipment
.
In general, with the accelerated development of the pharmaceutical industry, domestic pharmaceutical equipment companies are ushering in good news
.
However, it should be noted that the homogenization of domestic pharmaceutical equipment products is still serious, even among leading companies
.
In this context, only by continuing to do a good job in technological innovation, management innovation and institutional mechanism innovation and differentiation can domestic pharmaceutical equipment enterprises move towards a high level and high quality in the case of a high overlap rate in the domestic pharmaceutical equipment industry.
and accelerate the pace of import substitution
.
